- Home
- OCCI vs VSTM Comparison
OCCI vs VSTM Comparison
Compare OCCI & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- VSTM
- Stock Information
- Founded
- OCCI N/A
- VSTM 2010
- Country
- OCCI United States
- VSTM United States
- Employees
- OCCI N/A
- VSTM N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- OCCI Finance
- VSTM Health Care
- Exchange
- OCCI Nasdaq
- VSTM Nasdaq
- Market Cap
- OCCI 117.5M
- VSTM 132.0M
- IPO Year
- OCCI N/A
- VSTM 2012
- Fundamental
- Price
- OCCI $7.11
- VSTM $4.00
- Analyst Decision
- OCCI
- VSTM Strong Buy
- Analyst Count
- OCCI 0
- VSTM 8
- Target Price
- OCCI N/A
- VSTM $14.57
- AVG Volume (30 Days)
- OCCI 115.8K
- VSTM 962.7K
- Earning Date
- OCCI 12-11-2023
- VSTM 11-06-2024
- Dividend Yield
- OCCI 24.32%
- VSTM N/A
- EPS Growth
- OCCI N/A
- VSTM N/A
- EPS
- OCCI N/A
- VSTM N/A
- Revenue
- OCCI N/A
- VSTM $10,000,000.00
- Revenue This Year
- OCCI N/A
- VSTM N/A
- Revenue Next Year
- OCCI $10.19
- VSTM $108.05
- P/E Ratio
- OCCI N/A
- VSTM N/A
- Revenue Growth
- OCCI N/A
- VSTM N/A
- 52 Week Low
- OCCI $5.47
- VSTM $2.10
- 52 Week High
- OCCI $10.15
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- OCCI 46.64
- VSTM 56.35
- Support Level
- OCCI $7.02
- VSTM $3.72
- Resistance Level
- OCCI $7.42
- VSTM $4.15
- Average True Range (ATR)
- OCCI 0.12
- VSTM 0.37
- MACD
- OCCI 0.01
- VSTM -0.04
- Stochastic Oscillator
- OCCI 29.55
- VSTM 39.39
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.